NCT02206308
- Conditions
- B-cell Non Hodgkin's Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
- Locations
-
Not specified
Clinical trial condition
Immunoproliferative Disorders
Explore clinical trials studying Immunoproliferative Disorders. Study availability and eligibility vary by location and protocol.
9,977 public trials
2,028 recruiting studies
Immunoproliferative Disorders trial results
NCT00185965
- Conditions
- Bacterial Infections and Mycoses, Hemic and Lymphatic Diseases, Immune System Diseases, +13 more
- Locations
-
- Stanford University School of Medicine Stanford, California, United States
NCT00002941
- Conditions
- Burkitt Lymphoma, DNA Virus Infections, Dendritic Cell Sarcoma, Interdigitating, +22 more
- Locations
-
- University of Alabama at Birmingham Comprehensive Cancer Center Birmingham, Alabama, United States
- University of South Alabama Medical Center Mobile, Alabama, United States
- Phoenix Children's Hospital Phoenix, Arizona, United States
- Arizona Cancer Center Tucson, Arizona, United States
NCT00948090
- Conditions
- Hemic and Lymphatic Diseases, Hodgkin Disease, Immune System Diseases, +7 more
- Locations
-
- University of Alabama in Birmingham Birmingham, Alabama, United States
- Arizona Cancer Center Tucson, Arizona, United States
- Alta Bates Summit Medical Center Berkeley, California, United States
- Scripps Clinic La Jolla, California, United States
NCT01032681
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +12 more
- Locations
-
- Universitäts-Klinikum Mainz III.Medizinische Klinik Mainz, Germany
- Medizinische Klinik Universitätsklinikum Mannheim Medizinische Fakultät Mannheim Mannheim, Germany
- Istituto Oncologico della Svizzera Italiana Ospedale Regionale Bellinzona e Valli (IOSI) Bellinzona, Switzerland
- University of Lausanne Hospitals (CHUV) and Hospitals of Riveria-Chablais Lausanne, Switzerland
Completed
Evaluation of the Analgesy With Emla and/or Nitrous Oxide in Pediatric Patients for Lumbar Puncture
NCT00808171
- Conditions
- Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
- Locations
-
- Department of Pediatrics - Hematology section - Clinical Hospital of Minas Gerais Belo Horizonte, Minas Gerais, Brazil
Completed
Combination Chemotherapy in Treating Children With Very High Risk Acute Lymphocytic Leukemia
NCT00003783
- Conditions
- Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
- Locations
-
- Arizona Cancer Center Tucson, Arizona, United States
- Lucile Packard Children's Hospital at Stanford Palo Alto, California, United States
- Sutter Cancer Center Sacramento, California, United States
- Kaiser Permanente-Southern California Permanente Medical Group San Diego, California, United States
NCT00003217
- Conditions
- Burkitt Lymphoma, DNA Virus Infections, Epstein-Barr Virus Infections, +16 more
- Locations
-
- University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
- Lucile Packard Children's Hospital at Stanford Palo Alto, California, United States
- Children's Memorial Hospital, Chicago Chicago, Illinois, United States
- Hackensack University Medical Center Hackensack, New Jersey, United States
NCT00002757
- Conditions
- Burkitt Lymphoma, DNA Virus Infections, Dendritic Cell Sarcoma, Interdigitating, +19 more
- Locations
-
- Institut Gustave Roussy Villejuif, France
- Children's Hospital - Sheffield Sheffield, England, United Kingdom
Completed
Combination Chemotherapy in Treating Pediatric Patients With Advanced-Stage Large Cell Lymphoma
NCT00002618
- Conditions
- Dendritic Cell Sarcoma, Interdigitating, Hemic and Lymphatic Diseases, Histiocytic Disorders, Malignant, +11 more
- Locations
-
- Via Christi Regional Medical Center-Saint Francis Campus Wichita, Kansas, United States
- MBCCOP - LSU Medical Center New Orleans, Louisiana, United States
- Memorial Mission Hospital Asheville, North Carolina, United States
- Medical University of South Carolina Charleston, South Carolina, United States